Sanctura
Brand names,
Sanctura
Analogs
Sanctura
Brand Names Mixture
Sanctura
Chemical_Formula
C25H30NO3
Sanctura
RX_link
http://www.rxlist.com/cgi/generic3/sanctura.htm
Sanctura
fda sheet
Sanctura
msds (material safety sheet)
Sanctura
Synthesis Reference
No information avaliable
Sanctura
Molecular Weight
392.511 g/mol
Sanctura
Melting Point
No information avaliable
Sanctura
H2O Solubility
No information avaliable
Sanctura
State
Solid
Sanctura
LogP
No information avaliable
Sanctura
Dosage Forms
Tablet
Sanctura
Indication
For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, Detrusor instability and frequency of micturition
Sanctura
Pharmacology
Trospium is an antispasmodic, antimuscarinic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Receptor assays showed that trospium chloride has negligible affinity for nicotinic receptors as compared to muscarinic receptors at concentrations obtained from therapeutic doses.
Sanctura
Absorption
9.6%
Sanctura
side effects and Toxicity
No information avaliable
Sanctura
Patient Information
Patients should be informed that anticholinergic agents, such as Sanctura, may produce clinically
significant adverse effects related to anticholinergic pharmacological activity. For example, heat prostration (fever
and heat stroke due to decreased sweating) can occur when anticholinergics such as Sanctura are used in a hot
environment. Because anticholinergics such as Sanctura may also produce dizziness or blurred vision, patients should
be advised to exercise caution. Patients should be informed that alcohol may enhance the drowsiness caused by
anticholinergic agents.
Sanctura should be taken 1 hour prior to meals or on an empty stomach. If a dose is skipped, patients
are advised to take their next dose 1 hour prior to their next meal.
Sanctura
Organisms Affected
Humans and other mammals